Background Lung cancer is the leading cause of cancer-related death worldwide, with non-
small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has …

Introduction Nearly 60% of patients with non-small cell lung cancer (NSCLC) present with
metastatic disease, and approximately 20% have brain metastases (BrMs) at diagnosis …

Simple Summary There is conflicting evidence on the impact of TP53 co-mutations on
survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC) …

Background Patients with non-small cell lung cancer (NSCLC) who develop brain
metastases (BM) have a poor prognosis. This study aimed to construct a clinical prediction …

Patients with epidermal growth factor receptor (EGFR) exon 21 L858R substitution benefit
less from standard EGFR tyrosine kinase inhibitor (TKI) treatment, and whether anti …

Purpose Stereotactic radiosurgery (SRS) has become a standard approach for the treatment
of patients with few metastatic brain lesions. However, the optimal treatment approach for …

Evidences indicate that long non-coding RNAs (lncRNAs) are closely involved and
contributed to tumorigenesis and cancer progression. As a novel lncRNA, RP11-79H23. 3 …

Lung cancer is the leading cause of malignancy-related death in the United States and the
second most common cancer diagnosis worldwide. In the last two decades, lung cancer …

Background: Promisingly the technique of hippocampus sparing during WBRT (HS-WBRT)
might preserve NCFs. In this research, we examined oncological outcomes, with emphasis …

Purpose Epidermal growth factor receptor (EGFR) T790M-negative/unknown advanced non-
small cell lung cancer (NSCLC) patients lack subsequent approved targeted therapies. This …